These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19077754)

  • 1. Adherence to urate-lowering therapy.
    Day RO
    South Med J; 2009 Jan; 102(1):114-5. PubMed ID: 19077754
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout.
    Hill-McManus D; Soto E; Marshall S; Lane S; Hughes D
    Br J Clin Pharmacol; 2018 Jan; 84(1):142-152. PubMed ID: 28888218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic approach to hyperuricemia and gout in the light of recommendations.
    Lioté F
    Joint Bone Spine; 2016 Jul; 83(4):376-80. PubMed ID: 27085801
    [No Abstract]   [Full Text] [Related]  

  • 5. The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study.
    Yin R; Cao H; Fu T; Zhang Q; Zhang L; Li L; Gu Z
    Rheumatol Int; 2017 Jul; 37(7):1187-1194. PubMed ID: 28551724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on emerging urate-lowering therapies.
    Chohan S; Becker MA
    Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Gout and risk of Parkinson disease: a prospective study.
    Schlesinger I; Schlesinger N
    Neurology; 2008 Jul; 71(1):70; author reply 70. PubMed ID: 18598007
    [No Abstract]   [Full Text] [Related]  

  • 8. Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial.
    Mikuls TR; Cheetham TC; Levy GD; Rashid N; Kerimian A; Low KJ; Coburn BW; Redden DT; Saag KG; Foster PJ; Chen L; Curtis JR
    Am J Med; 2019 Mar; 132(3):354-361. PubMed ID: 30503879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why better treatment of gout is needed.
    So AK
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):63-5. PubMed ID: 27586807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and treatment of gout as a chronic disease.
    Perez-Ruiz F; Herrero-Beites AM
    Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Gout in a Hospital Setting: A Lost Opportunity.
    Wright S; Chapman PT; Frampton C; O'Donnell JL; Raja R; Stamp LK
    J Rheumatol; 2017 Oct; 44(10):1493-1498. PubMed ID: 28765252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.
    Schumacher HR; Evans RR; Saag KG; Clower J; Jennings W; Weinstein SP; Yancopoulos GD; Wang J; Terkeltaub R
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1462-70. PubMed ID: 22549879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout.
    Richardson JC; Liddle J; Mallen CD; Roddy E; Hider S; Prinjha S; Ziebland S
    BMC Musculoskelet Disord; 2016 Jun; 17():249. PubMed ID: 27267878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perspectives in gout: a review.
    Singh JA
    Curr Opin Rheumatol; 2019 Mar; 31(2):159-166. PubMed ID: 30575598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperuricemia: a laboratory finding needing treatment?].
    Keller C
    Verh Dtsch Ges Inn Med; 1990; 96():188-92. PubMed ID: 2092438
    [No Abstract]   [Full Text] [Related]  

  • 17. Casebook consults: improving outcomes in gout (multimedia activity).
    Doghramji PP; Mandell BF; Pope RS
    Am J Med; 2012 Aug; 125(8):S1. PubMed ID: 22840678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alkalit in the treatment of hyperuricemic syndrome].
    Gerová Z; Tvarozková Z
    Cas Lek Cesk; 1986 Nov; 125(46):1424-6. PubMed ID: 3815469
    [No Abstract]   [Full Text] [Related]  

  • 19. Gout: nonsteroidal anti-inflammatory drugs and colchicine to prevent painful flares during early urate-lowering therapy.
    Kuritzky L; Panchal R
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):397-401. PubMed ID: 21133750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New gout treatment approved.
    Traynor K
    Am J Health Syst Pharm; 2009 Apr; 66(7):606. PubMed ID: 19299362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.